FDA Reorganization Will Not Include John Taylor As Top Aide To Commissioner
This article was originally published in The Gray Sheet
Executive Summary
John Taylor’s exit from the agency comes as FDA Commissioner Margaret Hamburg awaits recommendations from a panel of senior agency officials on how to ensure the centers support Office of Regulatory Affairs’ activities without duplication.